Clinical trial design and selected drug safety issues for antibiotics used to treat community-acquired pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 47 Suppl 3, Issue , 2008, Pages

  Psaty, Bruce M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; BACTERIAL PNEUMONIA; CLINICAL TRIAL; COMMUNICABLE DISEASE; DRUG TOXICITY; HUMAN; METHODOLOGY; REVIEW; TREATMENT OUTCOME; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; COMMUNITY-ACQUIRED INFECTIONS; DRUG TOXICITY; HUMANS; PNEUMONIA, BACTERIAL; RESEARCH DESIGN; TREATMENT OUTCOME; UNITED STATES;

EID: 58149237045     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/591400     Document Type: Review

References (26)